| dc.description.abstract |
The genus Klebsiella belongs to the Enterobacteriaceae family and comprises Gram
negative, opportunistic, non-motile pathogen with a mucoid appearance. The
gastrointestinal tract serves as a reservoir for transfer of resistance genes and is often
the potential source for infections. Multidrug resistance strains of Klebsiella cause
severe nosocomial and community-acquired infections that are difficult to eradicate
using available antibiotics. The increase in the incidence of extended spectrum β
lactamases (ESBL) producing Klebsiella spp, has become a serious problem
worldwide, because of their antibiotic resistance. The emergence and spread of β
lactamase-producing Klebsiella spp has been associated with a substantial healthcare
burden resulting from therapeutic failures. Multidrug resistant Klebsiella strains are
resistant to extended-spectrum beta-lactam antibiotics, aminoglycosides, and
fluoroquinolones. The aim of this study was to determine phenotypic and genotypic
antimicrobial resistance profiles of Klebsiella species from children under five years
of age in Kisii and Homabay County hospitals (Western Kenya). Although AMR
bacterial infections pose a disproportionate public health challenge in sub-Saharan
Africa, epidemiological data are scarce in Kenya. This was a cross-sectional study
involving the use of 245 archived Klebsiella isolates. Systematic random sampling
was used, and Excel formula randomization was used to generate random numbers to
have a representative sample size from the two study sites. Antimicrobial resistance
profiling was conducted to determine phenotypic resistance patterns and ESBLs, and
producing Klebsiella Pneumoniae and Klebsiella oxytoca using antimicrobial
susceptibility tests methods described by Kirby Bauer, ESBL resistance genes were
analyzed using conventional PCR. Descriptive analyses were used to characterize
phenotypic AMR and carriage of β-lactamase-producing genes. The modified
Poisson regression models were used to assess correlates of phenotypic AMR. The
prevalence of β-lactamase carriage among Klebsiella spp. isolates at hospital
discharge was 62.8% (154/245). The study reported more than 58.2% Klebsiella spp.
isolates were resistant to a third-generation cephalosporin; more specifically, 154
(62.6%) were resistant to ceftriaxone, 148 (60.0%) were resistant to cefotaxime and
127 (52.0%) were resistant to ceftazidime. Antibiotic use during hospitalization
(adjusted prevalence ratio [aPR] =4.51; 95%CI: 1.79-11.4, p<0.001), longer duration
of hospitalization (aPR=1.42; 95%CI: 1.14-1.77, p<0.002), and access to treated
water (aPR=1.38; 95%CI: 1.12-1.71, p<0.003), were significant predictors of
phenotypically determined β-lactamase. All the 154 phenotypically determined β
lactamase-producing Klebsiella spp. isolates had at least one genetic marker of β
lactam/third-generation cephalosporin resistance. The most prevalent genes were
CTX-M (92.2%; 95%CI: 86.8–95.9) and SHV (92.2%; 95%CI: 86.8–95.9) followed
by TEM (57.1%; 95%CI: 48.9–65.1) and OXA (31.2%; 95%CI: 24.0–39.1),
respectively. Carriage of β-lactamase producing Klebsiella spp in stool is common
among children discharged from hospital in western Kenya and is associated with
longer duration of hospitalization, antibiotic use, and surprisingly access to treated
water. These findings emphasize the need for continued surveillance of antimicrobial
susceptibility patterns to inform the development and implementation of appropriate
treatment guidelines. In addition, the study recommends measures beyond
antimicrobial stewardship and infection control within hospitals, improved
xvi
sanitation, and access to safe drinking water to mitigate the spread of β-lactamase
producing Klebsiella pathogens. |
en_US |